Healthcare >> CEO Interviews >> May 13, 2003
ALAN E. SMITH is Senior Vice President, Research and Chief
Scientific Officer at Genzyme Corporation and has overall
responsibility for the company's science. Before Integrated
Genetics was acquired by Genzyme in 1989, Dr. Smith held the
position of Vice President and Scientific Director at IG. Prior
to joining IG in 1984, Dr. Smith was head of the Biochemistry
Division of the National Institute for Medical Research, Mill
Hill, London, England. Previous to that, he was a member of the
scientific staff of the Imperial Cancer Research Fund, London,
England. Dr. Smith has authored and co-authored over 180
publications in the areas of biochemistry, virology, molecular
biology and gene therapy. He received his Bachelor of Arts degree
in Biochemistry from Christ's College, Cambridge, England and
holds a Doctor of Philosophy degree from the Laboratory of
Molecular Biology, Cambridge, England. Profile
TWST: Would you begin with a broad brush of what you see going onin biotech at the moment?
Dr. Smith: Francis Collins has just announced the completion of
the goals in the Human Genome